Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients-Reference-Cited by-同舟云学术

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

Published:2013-07-29 Issue:3 Volume:28 Page:675-679
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Hebraud B,Leleu X,Lauwers-Cances V,Roussel M,Caillot D,Marit G,Karlin L,Hulin C,Gentil C,Guilhot F,Garderet L,Lamy T,Brechignac S,Pegourie B,Jaubert J,Dib M,Stoppa A-M,Sebban C,Fohrer C,Fontan J,Fruchart C,Macro M,Orsini-Piocelle F,Lepeu G,Sohn C,Corre J,Facon T,Moreau P,Attal M,Avet-Loiseau H

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2013225.pdf

Reference17 articles.

1. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blade J et al. International Staging System for multiple myeloma. J Clin Oncol 2005; 23: 3412–3420.

2. Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart K et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia 2009; 23: 2210–2221.

3. Avet-Loiseau H, Durie BG, Cavo M, Attal M, Gutierrez N, Haessler J et al. Combining fluorescent in situ hybridization (iFISH) data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group (IMWG) collaborative project. Leukemia 2013; 27: 711–717.

4. Chng WJ, Kumar S, Vanwier S, Ahmann G, Price-Troska T, Henderson K et al. Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling. Cancer Res 2007; 67: 2982–2989.

5. Facon T, Avet-Loiseau H, Guillerm G, Moreau P, Genevieve F, Zandecki M et al. Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a very powerful myeloma staging system for patients receiving high dose therapy. Blood 2001; 97: 1566–1571.

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Del(1p32) is an early and high-risk event in multiple myeloma patients with extraosseous disease;Blood Cancer Journal;2024-08-26

2. RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA;Mediterranean Journal of Hematology and Infectious Diseases;2024-06-29

3. Approach to High-Risk Multiple Myeloma;Hematology/Oncology Clinics of North America;2024-04

4. Cytogenetics in the management of multiple Myeloma: The guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10

5. Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma;Clinical Cancer Research;2023-07-14